Biotropics Malaysia Berhad Unveils Novel Brain Health Ingredient at Vitafoods Asia 2023

September 18, 2023 10:00 AM AEST | By Cision

Biotropics Malaysia Berhad Unveils Novel Brain Health Ingredient at Vitafoods Asia 2023 — Image source: Kalkine Media

Recent News

Albertsons Companies Southwest Division Volunteers at Alice Cooper’s S...

The Power of Water — Cummins Water Works

Pichai pushes back on antitrust remedies, hints at Apple Gemini talks

Seaport starts coverage of chip stocks, says sell Nvidia, buy Broadcom...

BANGKOK, Sept. 18, 2023 /PRNewswire/ -- September 20, 2023, Biotropics Malaysia Berhad, a leading producer of high-quality botanical extracts, is pleased to announce the launch of its novel BioKesum® leaf extract clinically shown to support brain health. BioKesum® leaf extract is sourced from the tropical BioKesum® plant that is endemic to the fauna of Malaysia.

Biotropics Malaysia HQ in Glenmarie Shah Alam Malaysia. Herbal extracts from the Malaysian biodiversity are given a new lease in the market as high value herbs designed for health supplements as well as functional food and beverage in over 35 countries.

As consumers place increasing importance on brain health and cognitive performance, demand is rising for natural ingredients that support memory, focus, mood and overall brain function. Market research firm Persistence Market Research estimates the global brain health supplements market will reach $12.1 billion by 2026, representing a compound annual growth rate of 8.5% from 2023 to 2026.

Biotropics' proprietary BioKesum® leaf extract is uniquely formulated to provide standardised levels of brain-nourishing compounds called flavonoids. In a double-blind, placebo-controlled clinical trial with 60 adults, BioKesum® leaf extract was shown to significantly improve memory, executive function and increase levels of Brain-Derived Neurotrophic Factor (BDNF) compared to placebo. BDNF plays a critical role in neuronal growth and resilience in the brain.

"We are excited to introduce BioKesum® leaf extract to the global nutraceutical market," says Biotropics Malaysia Berhad acting CEO, Haliza Ramli. "A common salad (or locally termed "ulam") in Malaysia, the revolutionized BioKesum® is an exotic source of brain-supporting flavonoids. Our clinical research demonstrates BioKesum® leaf extract's ability to positively impact BDNF levels and markers of cognitive function."

Biotropics is showcasing its BioKesum® leaf extract and the clinical research supporting its novel brain health benefits at Vitafoods Asia 2023 taking place September 20-22 in QSNCC, Bangkok, Thailand. Attendees are invited to visit Biotropics at Booth G34 to learn more about this innovative new ingredient and its applications for memory support supplements, nootropic formulations, and general brain health products.

Dr. Annie George will also be presenting a Nutrafocus session titled "Alternative and Complementary Pathway in Promoting Overall Wellbeing through Evidence Based Nutraceuticals" on September 21st at 2:30pm in the Innovation Theatre (Nutra highlighting BioKesum® leaf extract and Biotropics' work developing clinically-validated botanical ingredients).

Other clinically researched, premium botanicals showcased are Physta® Tongkat Ali for Men's and Women's Health & Energy, SLP+® for Women's Health and Nu-Femme® for Menopause Management, and AVCO® (Activated Virgin Coconut Oil) with broad-spectrum antimicrobial activity for personal care applications (acne and dandruff).

Those interested in learning more about Biotropics' ingredients can visit www.biotropicsmalaysia.com or Biotropics' social media accounts on Instagram, LinkedIn, Facebook and Twitter.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.